Advertisement
Advertisement
LEGN
Legend Biotech Corporation - ADR
18.71
USDSponsored
-0.41
-2.14%
Oct 08, 15:59 UTC -4
Closed
After-Market
18.62
-0.09
-0.46%
LEGN Earnings Reports
Positive Surprise Ratio
LEGN beat 10 of 23 last estimates.
43%
Next Report
Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$365.32M
/$0.00
Implied change from Q2 26 (Revenue/ EPS)
-5.72%
/-100.00%
Implied change from Q3 25 (Revenue/ EPS)
+34.15%
/-100.00%
Legend Biotech Corporation - ADR earnings per share and revenue
On Aug 11, 2026, LEGN reported earnings of 0.18 USD per share (EPS) for Q2 26, beating the estimate of 0.07 USD, resulting in a 135.60% surprise. Revenue reached 387.50 million, compared to an expected 362.89 million, with a 6.78% difference. The market reacted with a +5.66% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 365.32 million USD, implying an decrease of -100.00% EPS, and decrease of -5.72% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nanobiotix S.A. - ADR
Report Date
Sep 25, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.70
Surprise
-496.76%
Inventiva S.A. - ADR
Report Date
Sep 28, 2026 For Q2 26
Estimate
-$0.37
Actual
-$0.25
Surprise
+33.55%
Rezolute, Inc. Common Stock (NV)
Report Date
Sep 24, 2026 For Q4 26
Estimate
-$0.15
Actual
-$0.20
Surprise
-32.45%
Palatin Technologies, Inc. Common Stock
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$1.21
Actual
-$1.11
Surprise
+8.42%
NeuroSense Therapeutics Ltd. Ordinary Shares
Report Date
Sep 25, 2026 For Q2 26
Estimate
-$3.26
Actual
-$2.10
Surprise
+35.66%
FAQ
What were Legend Biotech Corporation - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Legend Biotech Corporation - ADR reported EPS of $0.18, beating estimates by 135.6%, and revenue of $387.50M, 6.78% above expectations.
How did the market react to Legend Biotech Corporation - ADR's Q2 2026 earnings?
The stock price moved up 5.66%, changed from $20.66 before the earnings release to $21.83 the day after.
When is Legend Biotech Corporation - ADR expected to report next?
The next earning report is scheduled for Nov 10, 2026.
What are the forecasts for Legend Biotech Corporation - ADR's next earnings report?
Based on 7
analysts, Legend Biotech Corporation - ADR is expected to report EPS of -- and revenue of $365.32M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.